 Kristine Kuhn
Concepts (221)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Spondylarthritis | 10 | 2022 | 35 | 5.120 |
Why?
| | Spondylitis, Ankylosing | 6 | 2022 | 42 | 3.310 |
Why?
| | Gastrointestinal Microbiome | 12 | 2023 | 538 | 3.040 |
Why?
| | Arthritis, Rheumatoid | 13 | 2023 | 990 | 2.320 |
Why?
| | Microbiota | 8 | 2023 | 655 | 2.310 |
Why?
| | Arthritis, Experimental | 6 | 2023 | 133 | 2.110 |
Why?
| | Intestines | 5 | 2021 | 330 | 1.840 |
Why?
| | Interleukin-17 | 3 | 2023 | 105 | 1.770 |
Why?
| | Inflammatory Bowel Diseases | 8 | 2023 | 290 | 1.690 |
Why?
| | Arthritis | 4 | 2022 | 112 | 1.620 |
Why?
| | Crohn Disease | 3 | 2023 | 197 | 1.490 |
Why?
| | Intestinal Mucosa | 6 | 2023 | 529 | 1.420 |
Why?
| | Intraepithelial Lymphocytes | 2 | 2018 | 12 | 1.270 |
Why?
| | Inflammation | 10 | 2023 | 2545 | 1.160 |
Why?
| | Immunity, Mucosal | 5 | 2020 | 85 | 1.150 |
Why?
| | Rheumatology | 2 | 2023 | 87 | 1.030 |
Why?
| | Tryptophan | 2 | 2023 | 138 | 0.950 |
Why?
| | Th17 Cells | 1 | 2024 | 57 | 0.930 |
Why?
| | Autoantibodies | 5 | 2022 | 1334 | 0.890 |
Why?
| | Interleukin-6 | 2 | 2017 | 685 | 0.840 |
Why?
| | T-Lymphocytes | 3 | 2021 | 1770 | 0.840 |
Why?
| | Immunoglobulin A | 1 | 2022 | 174 | 0.800 |
Why?
| | Mentoring | 1 | 2022 | 101 | 0.770 |
Why?
| | Dysbiosis | 3 | 2021 | 148 | 0.760 |
Why?
| | Metagenomics | 1 | 2021 | 134 | 0.720 |
Why?
| | Metabolomics | 2 | 2022 | 540 | 0.700 |
Why?
| | Colon | 3 | 2022 | 237 | 0.690 |
Why?
| | Bacteroidaceae | 1 | 2017 | 3 | 0.620 |
Why?
| | Citrobacter rodentium | 1 | 2017 | 6 | 0.620 |
Why?
| | Osteoarthritis | 1 | 2020 | 178 | 0.610 |
Why?
| | Enterobacteriaceae Infections | 1 | 2017 | 34 | 0.600 |
Why?
| | Biomedical Research | 1 | 2022 | 600 | 0.580 |
Why?
| | Mice | 18 | 2024 | 15446 | 0.540 |
Why?
| | Skin | 2 | 2020 | 657 | 0.540 |
Why?
| | Gastrointestinal Tract | 1 | 2018 | 174 | 0.540 |
Why?
| | Autoimmune Diseases | 3 | 2019 | 398 | 0.530 |
Why?
| | Collagen Type II | 2 | 2018 | 48 | 0.480 |
Why?
| | Animals | 21 | 2024 | 33152 | 0.480 |
Why?
| | Collagen | 4 | 2023 | 433 | 0.470 |
Why?
| | Cytokines | 6 | 2022 | 1880 | 0.400 |
Why?
| | Antigens | 2 | 2013 | 319 | 0.380 |
Why?
| | Humans | 37 | 2023 | 118251 | 0.380 |
Why?
| | Bacteria | 2 | 2015 | 751 | 0.380 |
Why?
| | Receptors, Complement 3d | 2 | 2008 | 130 | 0.370 |
Why?
| | Immunity, Innate | 3 | 2020 | 744 | 0.340 |
Why?
| | Receptors, Complement 3b | 1 | 2008 | 83 | 0.320 |
Why?
| | Antibodies, Monoclonal | 2 | 2022 | 1279 | 0.310 |
Why?
| | RNA, Ribosomal, 16S | 3 | 2019 | 507 | 0.300 |
Why?
| | Cell Proliferation | 1 | 2014 | 2262 | 0.300 |
Why?
| | Germ-Free Life | 3 | 2021 | 30 | 0.260 |
Why?
| | Symbiosis | 2 | 2017 | 63 | 0.260 |
Why?
| | Hypoxia-Inducible Factor 1 | 2 | 2015 | 64 | 0.250 |
Why?
| | Feces | 3 | 2022 | 392 | 0.250 |
Why?
| | Peptides, Cyclic | 1 | 2006 | 259 | 0.240 |
Why?
| | Disease Models, Animal | 6 | 2022 | 3676 | 0.240 |
Why?
| | Ileitis | 1 | 2023 | 25 | 0.230 |
Why?
| | Bifidobacterium longum | 1 | 2022 | 5 | 0.220 |
Why?
| | Autoantigens | 2 | 2022 | 397 | 0.220 |
Why?
| | Oryza | 1 | 2022 | 21 | 0.220 |
Why?
| | Erythema Nodosum | 1 | 2022 | 3 | 0.210 |
Why?
| | Colitis | 2 | 2015 | 219 | 0.210 |
Why?
| | Biomarkers | 3 | 2022 | 3567 | 0.210 |
Why?
| | Pyoderma Gangrenosum | 1 | 2022 | 5 | 0.210 |
Why?
| | Case-Control Studies | 2 | 2021 | 3156 | 0.210 |
Why?
| | Disease Susceptibility | 2 | 2021 | 330 | 0.210 |
Why?
| | Anti-Citrullinated Protein Antibodies | 2 | 2021 | 89 | 0.200 |
Why?
| | Granzymes | 1 | 2021 | 40 | 0.200 |
Why?
| | Antirheumatic Agents | 1 | 2023 | 254 | 0.200 |
Why?
| | Mentors | 1 | 2022 | 165 | 0.190 |
Why?
| | Uveitis | 1 | 2022 | 116 | 0.190 |
Why?
| | Cell Differentiation | 2 | 2024 | 1746 | 0.180 |
Why?
| | Toll-Like Receptors | 1 | 2020 | 167 | 0.180 |
Why?
| | Metabolic Networks and Pathways | 1 | 2021 | 175 | 0.180 |
Why?
| | Bacteriophages | 1 | 2021 | 76 | 0.180 |
Why?
| | Bacteroides | 2 | 2019 | 17 | 0.180 |
Why?
| | Glucose Intolerance | 1 | 2021 | 139 | 0.170 |
Why?
| | Fatty Acids, Volatile | 2 | 2018 | 47 | 0.170 |
Why?
| | Epithelial Cells | 2 | 2015 | 951 | 0.170 |
Why?
| | Homeodomain Proteins | 1 | 2022 | 469 | 0.170 |
Why?
| | Disease | 1 | 2019 | 87 | 0.170 |
Why?
| | Gene Expression Regulation, Bacterial | 1 | 2021 | 283 | 0.170 |
Why?
| | Adaptive Immunity | 1 | 2020 | 160 | 0.170 |
Why?
| | Lymphocytes | 1 | 2020 | 346 | 0.160 |
Why?
| | Immunoglobulin G | 1 | 2022 | 785 | 0.160 |
Why?
| | Mice, Transgenic | 2 | 2022 | 2012 | 0.160 |
Why?
| | Immune System | 1 | 2019 | 181 | 0.160 |
Why?
| | Immune Tolerance | 1 | 2020 | 330 | 0.160 |
Why?
| | Mucous Membrane | 1 | 2018 | 112 | 0.160 |
Why?
| | Homosexuality, Male | 1 | 2019 | 165 | 0.160 |
Why?
| | Vascular Diseases | 1 | 2021 | 241 | 0.160 |
Why?
| | Monocytes | 1 | 2020 | 511 | 0.160 |
Why?
| | HIV | 1 | 2019 | 209 | 0.160 |
Why?
| | Pilot Projects | 1 | 2022 | 1405 | 0.150 |
Why?
| | Cell Membrane Permeability | 1 | 2017 | 87 | 0.150 |
Why?
| | Computational Biology | 1 | 2021 | 541 | 0.150 |
Why?
| | Myeloid Differentiation Factor 88 | 1 | 2017 | 95 | 0.150 |
Why?
| | Obesity | 2 | 2021 | 2715 | 0.140 |
Why?
| | Mice, Inbred C57BL | 5 | 2022 | 4887 | 0.140 |
Why?
| | Antibody Formation | 2 | 2008 | 275 | 0.140 |
Why?
| | Histones | 1 | 2020 | 546 | 0.130 |
Why?
| | Sulfatases | 1 | 2015 | 1 | 0.130 |
Why?
| | Secretory Vesicles | 1 | 2015 | 24 | 0.130 |
Why?
| | Claudin-1 | 1 | 2015 | 17 | 0.130 |
Why?
| | Software | 1 | 2019 | 566 | 0.130 |
Why?
| | Non-alcoholic Fatty Liver Disease | 1 | 2018 | 277 | 0.130 |
Why?
| | Antigens, Bacterial | 1 | 2015 | 116 | 0.130 |
Why?
| | Tight Junctions | 1 | 2015 | 69 | 0.130 |
Why?
| | Molecular Mimicry | 1 | 2014 | 40 | 0.120 |
Why?
| | Pandemics | 1 | 2022 | 1338 | 0.120 |
Why?
| | Autoimmunity | 3 | 2020 | 831 | 0.120 |
Why?
| | Gene Expression Profiling | 1 | 2021 | 1590 | 0.120 |
Why?
| | Homeostasis | 1 | 2017 | 589 | 0.120 |
Why?
| | Diagnosis, Differential | 1 | 2018 | 1379 | 0.120 |
Why?
| | Genome-Wide Association Study | 1 | 2020 | 1318 | 0.110 |
Why?
| | Physicians | 1 | 2021 | 792 | 0.110 |
Why?
| | Rheumatologists | 2 | 2023 | 12 | 0.110 |
Why?
| | Anti-Bacterial Agents | 1 | 2022 | 1514 | 0.110 |
Why?
| | Wound Healing | 1 | 2014 | 270 | 0.110 |
Why?
| | Host-Pathogen Interactions | 1 | 2015 | 299 | 0.110 |
Why?
| | Mice, Inbred DBA | 3 | 2007 | 172 | 0.100 |
Why?
| | Mice, Knockout | 1 | 2017 | 2664 | 0.100 |
Why?
| | Biopsy | 1 | 2014 | 1078 | 0.100 |
Why?
| | Adult | 8 | 2021 | 31324 | 0.100 |
Why?
| | Citrulline | 2 | 2008 | 40 | 0.100 |
Why?
| | Male | 12 | 2021 | 57474 | 0.090 |
Why?
| | Middle Aged | 7 | 2021 | 27510 | 0.090 |
Why?
| | Female | 11 | 2022 | 61261 | 0.090 |
Why?
| | United States | 2 | 2022 | 12488 | 0.090 |
Why?
| | Rheumatoid Factor | 2 | 2008 | 156 | 0.090 |
Why?
| | Porphyromonas gingivalis | 1 | 2008 | 15 | 0.080 |
Why?
| | Freund's Adjuvant | 1 | 2008 | 17 | 0.080 |
Why?
| | Periodontitis | 1 | 2008 | 42 | 0.080 |
Why?
| | HIV Infections | 2 | 2019 | 2454 | 0.080 |
Why?
| | Antibodies, Bacterial | 1 | 2008 | 124 | 0.080 |
Why?
| | Joints | 1 | 2008 | 85 | 0.080 |
Why?
| | Complement C3 | 1 | 2008 | 191 | 0.070 |
Why?
| | Immunoglobulin Isotypes | 1 | 2006 | 32 | 0.070 |
Why?
| | Lupus Vulgaris | 1 | 2006 | 5 | 0.070 |
Why?
| | Antigen-Antibody Reactions | 1 | 2006 | 50 | 0.070 |
Why?
| | Antibody Specificity | 1 | 2006 | 182 | 0.070 |
Why?
| | Synovial Membrane | 1 | 2006 | 72 | 0.070 |
Why?
| | Gene Expression Regulation | 1 | 2015 | 2435 | 0.070 |
Why?
| | Cohort Studies | 3 | 2021 | 5078 | 0.070 |
Why?
| | Immunization | 1 | 2008 | 412 | 0.070 |
Why?
| | Fibrinogen | 1 | 2006 | 150 | 0.070 |
Why?
| | Apoptosis | 1 | 2014 | 2461 | 0.070 |
Why?
| | Paneth Cells | 1 | 2023 | 17 | 0.060 |
Why?
| | Butyrates | 1 | 2023 | 54 | 0.060 |
Why?
| | Risk Factors | 3 | 2023 | 8958 | 0.060 |
Why?
| | Cattle | 1 | 2006 | 974 | 0.060 |
Why?
| | Azoxymethane | 1 | 2022 | 17 | 0.050 |
Why?
| | Dextran Sulfate | 1 | 2022 | 71 | 0.050 |
Why?
| | B-Lymphocytes | 1 | 2007 | 767 | 0.050 |
Why?
| | Delayed Diagnosis | 1 | 2021 | 78 | 0.050 |
Why?
| | HLA-B27 Antigen | 1 | 2021 | 11 | 0.050 |
Why?
| | Citrullination | 1 | 2020 | 12 | 0.050 |
Why?
| | Carcinogenesis | 1 | 2022 | 181 | 0.050 |
Why?
| | Interleukin-2 | 1 | 2001 | 416 | 0.050 |
Why?
| | Healthy Volunteers | 1 | 2021 | 194 | 0.050 |
Why?
| | Cell Transformation, Neoplastic | 1 | 2022 | 317 | 0.050 |
Why?
| | Immunophenotyping | 1 | 2020 | 276 | 0.050 |
Why?
| | Fluorescent Antibody Technique | 1 | 2020 | 409 | 0.040 |
Why?
| | Aged | 4 | 2021 | 19594 | 0.040 |
Why?
| | Consensus | 1 | 2022 | 533 | 0.040 |
Why?
| | Killer Cells, Natural | 1 | 2001 | 380 | 0.040 |
Why?
| | Buspirone | 1 | 1998 | 5 | 0.040 |
Why?
| | Diet, Western | 1 | 2018 | 69 | 0.040 |
Why?
| | Serotonin Receptor Agonists | 1 | 1998 | 28 | 0.040 |
Why?
| | Lorazepam | 1 | 1998 | 24 | 0.040 |
Why?
| | Interferon-gamma | 1 | 2001 | 735 | 0.040 |
Why?
| | Anti-Anxiety Agents | 1 | 1998 | 38 | 0.040 |
Why?
| | Organ Specificity | 1 | 2018 | 274 | 0.040 |
Why?
| | Mitochondria | 1 | 2023 | 785 | 0.040 |
Why?
| | DNA, Bacterial | 1 | 2019 | 313 | 0.040 |
Why?
| | Inflammation Mediators | 1 | 2020 | 497 | 0.040 |
Why?
| | Bile Acids and Salts | 1 | 2018 | 179 | 0.040 |
Why?
| | Early Diagnosis | 1 | 2018 | 227 | 0.040 |
Why?
| | Phylogeny | 1 | 2021 | 817 | 0.040 |
Why?
| | Time Factors | 2 | 2006 | 6368 | 0.040 |
Why?
| | In Vitro Techniques | 1 | 2019 | 1082 | 0.040 |
Why?
| | Qualitative Research | 1 | 2021 | 952 | 0.040 |
Why?
| | Procollagen | 1 | 1976 | 21 | 0.040 |
Why?
| | Anxiety Disorders | 1 | 1998 | 310 | 0.030 |
Why?
| | Sexual Behavior | 1 | 2019 | 435 | 0.030 |
Why?
| | Chromatin Immunoprecipitation | 1 | 2015 | 134 | 0.030 |
Why?
| | Genes, Bacterial | 1 | 2015 | 161 | 0.030 |
Why?
| | Diet | 1 | 2022 | 1143 | 0.030 |
Why?
| | Mutagenesis, Site-Directed | 1 | 2015 | 363 | 0.030 |
Why?
| | Adiposity | 1 | 2018 | 508 | 0.030 |
Why?
| | Gene Deletion | 1 | 2015 | 359 | 0.030 |
Why?
| | Transcriptional Activation | 1 | 2015 | 347 | 0.030 |
Why?
| | Follow-Up Studies | 1 | 2022 | 4574 | 0.030 |
Why?
| | Cell Line | 2 | 2015 | 2693 | 0.030 |
Why?
| | Mothers | 1 | 2018 | 675 | 0.030 |
Why?
| | Oxygen Consumption | 1 | 2015 | 585 | 0.030 |
Why?
| | Fibroblasts | 1 | 1976 | 835 | 0.030 |
Why?
| | Cross-Sectional Studies | 1 | 2022 | 4521 | 0.020 |
Why?
| | Quality of Life | 1 | 2021 | 2355 | 0.020 |
Why?
| | Promoter Regions, Genetic | 1 | 2015 | 1157 | 0.020 |
Why?
| | Liver | 1 | 2018 | 1803 | 0.020 |
Why?
| | Young Adult | 2 | 2019 | 10731 | 0.020 |
Why?
| | Signal Transduction | 2 | 2015 | 4688 | 0.020 |
Why?
| | Immunoglobulins | 1 | 2008 | 152 | 0.020 |
Why?
| | Pregnancy | 1 | 2018 | 5671 | 0.020 |
Why?
| | Receptors, Antigen, B-Cell | 1 | 2007 | 101 | 0.020 |
Why?
| | C-Reactive Protein | 1 | 2008 | 364 | 0.020 |
Why?
| | Infant | 1 | 2018 | 8254 | 0.020 |
Why?
| | Reference Values | 1 | 2006 | 770 | 0.020 |
Why?
| | Lymphocyte Activation | 1 | 2007 | 1062 | 0.010 |
Why?
| | Mice, Inbred CBA | 1 | 2001 | 59 | 0.010 |
Why?
| | Sensitivity and Specificity | 1 | 2006 | 1787 | 0.010 |
Why?
| | Interleukin-12 | 1 | 2001 | 110 | 0.010 |
Why?
| | Peptides | 1 | 2006 | 879 | 0.010 |
Why?
| | Adolescent | 1 | 2019 | 18364 | 0.010 |
Why?
| | Manifest Anxiety Scale | 1 | 1998 | 3 | 0.010 |
Why?
| | Recombinant Proteins | 1 | 2001 | 1302 | 0.010 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2001 | 1937 | 0.010 |
Why?
| | Ehlers-Danlos Syndrome | 1 | 1976 | 14 | 0.010 |
Why?
| | Ascorbic Acid | 1 | 1976 | 120 | 0.010 |
Why?
| | Double-Blind Method | 1 | 1998 | 1683 | 0.010 |
Why?
| | Treatment Outcome | 1 | 1998 | 9319 | 0.000 |
Why?
|
|
Kuhn's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|